Ideal Patients, 1896–Present

Advances in imaging technology over the last century have allowed increasingly sophisticated glimpses into the ancient processes of mummification.

Written byAmy Schleunes
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, CHRISTOPHERARNDT

They don’t move, they don’t complain, and they’re impervious to X-ray damage. In other words, mummies are “a perfect subject for medical radiography,” according to conservator JP Brown of Chicago’s Field Museum of Natural History.

Scientists figured this out early on: just months after Wilhelm Roentgen’s discovery of X-rays in the fall of 1895, a physicist, Walter Koenig, captured the first radiographic images of mummified remains at the Physical Society of Frankfurt-am-Main. Up until that point, studying mummies had mostly meant unwrapping them, a process that Brown notes is “necessarily destructive.” A few decades later, the Field Museum became a pioneer of mummy imaging. Edward Jerman of the Victor X-Ray Corporation of Chicago volunteered his services and radiographed 32 ancient Egyptian and Peruvian mummies in the museum’s collection with what curator Berthold Lauer called “such gratifying and convincing results” that museum president Stanley Field opened a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile

Published In

April 2020

Exercise for Cancer

Molecular clues link physical activity to improved patient outcomes

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies